Literature DB >> 19150425

PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination.

Shitao Li1, Lingyan Wang, Martin E Dorf.   

Abstract

Tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key mediator in TNF signaling. Previous studies suggested that TRAF2 functions as an adaptor in the NF-kappaB and AP-1 pathways. However, the precise molecular mechanisms by which TRAF2 relays signals are unknown. We previously reported that TRAF2 is phosphorylated following TNF stimulation and now identify the PKC kinases responsible for phosphorylation. Phosphorylated TRAF2 facilitates recruitment of IKKalpha and IKKbeta to the TNF receptor. Phosphorylation also determines K63-linked polyubiquitination of TRAF2 at lysine 31. TRAF2 K63-linked ubiquitination contributes to associations with TAB2/3 and activation of the downstream IKK and JNK kinases. The combined data reveal that phosphorylation of TRAF2 plays a critical role in TNF signaling by directing the IKK complex to the membrane, promoting TRAF2 K63-linked ubiquitination, and positioning the IKKalpha and IKKbeta chains with the TAK1/TAB kinase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150425      PMCID: PMC2643372          DOI: 10.1016/j.molcel.2008.11.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

2.  Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs.

Authors:  John C Obenauer; Lewis C Cantley; Michael B Yaffe
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 3.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

4.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.

Authors:  Atsuhiro Kanayama; Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Mei Hong; Abdullah Shaito; Yu-Hsin Chiu; Li Deng; Zhijian J Chen
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

5.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.

Authors:  M Rothe; V Sarma; V M Dixit; D V Goeddel
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

6.  Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.

Authors:  W C Yeh; A Shahinian; D Speiser; J Kraunus; F Billia; A Wakeham; J L de la Pompa; D Ferrick; B Hum; N Iscove; P Ohashi; M Rothe; D V Goeddel; T W Mak
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

7.  A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.

Authors:  Eric D Tang; Cun-Yu Wang; Yue Xiong; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

8.  TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown.

Authors:  S Schütze; K Potthoff; T Machleidt; D Berkovic; K Wiegmann; M Krönke
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

9.  The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.

Authors:  Thomas H Lee; Jennifer Shank; Nicole Cusson; Michelle A Kelliher
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

10.  Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C.

Authors:  T Machleidt; B Krämer; D Adam; B Neumann; S Schütze; K Wiegmann; M Krönke
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  52 in total

1.  Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.

Authors:  Alexey V Sorokin; Binoj C Nair; Yongkun Wei; Kathryn E Aziz; Valentina Evdokimova; Mien-Chie Hung; Junjie Chen
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

2.  Polyubiquitination of transforming growth factor β (TGFβ)-associated kinase 1 mediates nuclear factor-κB activation in response to different inflammatory stimuli.

Authors:  Anahita Hamidi; Verena von Bulow; Rosita Hamidi; Nicolas Winssinger; Sofia Barluenga; Carl-Henrik Heldin; Marene Landström
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

3.  RACK1 modulates NF-κB activation by interfering with the interaction between TRAF2 and the IKK complex.

Authors:  Fan Yao; Ling-Yun Long; Yue-Zhen Deng; Yuan-Yuan Feng; Guo-Yuan Ying; Wen-Dai Bao; Guo Li; Dong-Xian Guan; Yin-Qiu Zhu; Jing-Jing Li; Dong Xie
Journal:  Cell Res       Date:  2013-12-10       Impact factor: 25.617

4.  LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO.

Authors:  Jixiao Niu; Yuling Shi; Kazuhiro Iwai; Zhao-Hui Wu
Journal:  EMBO J       Date:  2011-08-02       Impact factor: 11.598

Review 5.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

6.  NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.

Authors:  Collin M Blakely; Evangelos Pazarentzos; Victor Olivas; Saurabh Asthana; Jenny Jiacheng Yan; Irena Tan; Gorjan Hrustanovic; Elton Chan; Luping Lin; Dana S Neel; William Newton; Kathryn L Bobb; Timothy R Fouts; Jeffrey Meshulam; Matthew A Gubens; David M Jablons; Jeffrey R Johnson; Sourav Bandyopadhyay; Nevan J Krogan; Trever G Bivona
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

Review 7.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

8.  Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.

Authors:  Yoshihisa Tsuji; Tomohiro Watanabe; Masatoshi Kudo; Hidenori Arai; Warren Strober; Tsutomu Chiba
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

Review 9.  TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.

Authors:  Lauren M Workman; Hasem Habelhah
Journal:  Cell Signal       Date:  2013-04-21       Impact factor: 4.315

Review 10.  Caspase control: protagonists of cancer cell apoptosis.

Authors:  M V Fiandalo; N Kyprianou
Journal:  Exp Oncol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.